Exploring the Impact of Silicosis Incidence on Tuberculosis Mortality and Morbidity: A Multi-Country Study.


Journal

Medical sciences (Basel, Switzerland)
ISSN: 2076-3271
Titre abrégé: Med Sci (Basel)
Pays: Switzerland
ID NLM: 101629322

Informations de publication

Date de publication:
01 10 2023
Historique:
received: 16 08 2023
revised: 03 09 2023
accepted: 19 09 2023
medline: 25 10 2023
pubmed: 24 10 2023
entrez: 24 10 2023
Statut: epublish

Résumé

There are several risk factors attributed to tuberculosis (TB) mortality and morbidity. There are few studies and systematic reviews showing the association of silicosis and tuberculosis at a country level. Very limited studies have been conducted using multi-country data in studying the association of incidence of silicosis with TB mortality and morbidity. Hence, the aim of this research was to explore the association of incidence of silicosis and other important risk factors with TB mortality and morbidity using multi-country data. Data from 217 WHO region countries were utilized, sourcing TB-related statistics from the Institute of Health Metrics and Evaluation and additional risk factors from the Demographic and Health Survey, Global Burden of Disease, and World Bank for 2019. Regression analysis was conducted to examine the association between silicosis incidence and TB outcomes. The study found an average silicosis incidence of 121.92 per 100,000 population. Additionally, 62.69% of the sample population are exposed to air pollution from solid fuel cooking. Sanitation access stands at an average of 59.67%. Regression outcomes indicate that while alcohol consumption's influence on TB is not statistically significant, a unit increase in silicosis incidence significantly elevates TB deaths (235.9, The burden of silicosis is found to be one of the important determinants of deaths, YLL, and YLD due to tuberculosis. Country-specific strategies to prevent and control silicosis is a need of the hour.

Identifiants

pubmed: 37873748
pii: medsci11040063
doi: 10.3390/medsci11040063
pmc: PMC10594424
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

BMC Med. 2021 Sep 9;19(1):203
pubmed: 34496845
Int J Occup Environ Health. 1997 Jul;3(3):163-170
pubmed: 9891114
Trop Med Infect Dis. 2020 Jul 24;5(3):
pubmed: 32722014
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):281-285
pubmed: 32191687
Sci Rep. 2021 Jan 22;11(1):2113
pubmed: 33483542
BMC Pulm Med. 2019 Oct 21;19(1):182
pubmed: 31638950
Medicine (Baltimore). 2016 Sep;95(37):e4748
pubmed: 27631224
Indian J Tuberc. 2016 Jul;63(3):167-170
pubmed: 27865238
BMC Public Health. 2021 May 20;21(1):953
pubmed: 34016067
MMWR Recomm Rep. 2000 Jun 9;49(RR-6):1-51
pubmed: 10881762
Occup Environ Med. 2003 Feb;60(2):122-9
pubmed: 12554840
Lancet Glob Health. 2021 Dec;9(12):e1679-e1687
pubmed: 34798027
Food Nutr Bull. 2010 Dec;31(4):S345-64
pubmed: 21214037
Am J Epidemiol. 2011 Oct 1;174(7):839-48
pubmed: 21828370
Int J Infect Dis. 2021 Sep;110:385-393
pubmed: 34333118
Pulm Med. 2013;2013:828939
pubmed: 23476764
Front Public Health. 2020 Apr 07;8:107
pubmed: 32318535
PLoS One. 2015 Apr 23;10(4):e0124260
pubmed: 25905900
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Am J Infect Control. 2006 Dec;34(10):676-9
pubmed: 17161745
BMC Public Health. 2021 Nov 11;21(1):2065
pubmed: 34763696
Indian J Med Res. 2005 Apr;121(4):377-94
pubmed: 15817951
BMC Public Health. 2010 May 19;10:259
pubmed: 20482835
Balkan Med J. 2021 Nov;38(6):374-381
pubmed: 34860165
BMC Pulm Med. 2018 May 3;18(1):66
pubmed: 29724218
Lancet Infect Dis. 2018 Dec;18(12):1329-1349
pubmed: 30507459
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32513784
Trans R Soc Trop Med Hyg. 2018 Jun 1;112(6):272-278
pubmed: 29931208
BMC Public Health. 2017 Aug 3;18(1):93
pubmed: 28774280

Auteurs

Muayad Albadrani (M)

Department of Family and Community Medicine, College of Medicine, Taibah University, Al-Madinah al-Munawwarah 42353, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH